Erythromycin + Ivacaftor Interaction
Moderateinteraction on record
Description
Therefore, a reduction of the KALYDECO dosage is recommended for patients aged 6 months and older taking concomitant moderate CYP3A inhibitors, such as fluconazole and erythromycin.
Source: FDA drug label - ivacaftor